{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:25:51Z","timestamp":1791584751100,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"private Huntington's Disease community donations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00415-024-12728-z","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:22:24Z","timestamp":1734006144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cognitive impairment predicts medication discrepancies in Huntington\u2019s Disease: patient self-report compared to pharmacy records"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1160-0920","authenticated-orcid":false,"given":"Stephanie","family":"Feleus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5028-4288","authenticated-orcid":false,"given":"Mai-Ly T. D.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6084-8317","authenticated-orcid":false,"given":"Laura C. M.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-1133","authenticated-orcid":false,"given":"Raymund A. C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-2468","authenticated-orcid":false,"given":"Susanne T.","family":"de Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"12728_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"12728_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"JS Paulsen","year":"2011","unstructured":"Paulsen JS (2011) Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 11(5):474\u2013483","journal-title":"Curr Neurol Neurosci Rep"},{"key":"12728_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fneur.2019.00710","volume":"10","author":"AC Bachoud-Levi","year":"2019","unstructured":"Bachoud-Levi AC et al (2019) International Guidelines for the Treatment of Huntington\u2019s Disease. Front Neurol 10:710","journal-title":"Front Neurol"},{"issue":"4","key":"12728_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1039856218766120","volume":"26","author":"SM Loi","year":"2018","unstructured":"Loi SM et al (2018) Huntington\u2019s disease: Managing neuropsychiatric symptoms in Huntington\u2019s disease. Australas Psychiatry 26(4):376\u2013380","journal-title":"Australas Psychiatry"},{"issue":"10","key":"12728_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/oxfordjournals.aje.a117563","volume":"142","author":"SL West","year":"1995","unstructured":"West SL et al (1995) Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 142(10):1103\u20131112","journal-title":"Am J Epidemiol"},{"issue":"10","key":"12728_CR6","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s11136-018-1912-6","volume":"27","author":"NE Carlozzi","year":"2018","unstructured":"Carlozzi NE et al (2018) Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? Qual Life Res 27(10):2541\u20132555","journal-title":"Qual Life Res"},{"issue":"1","key":"12728_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/0963721409359277","volume":"19","author":"N Cowan","year":"2010","unstructured":"Cowan N (2010) The magical mystery four: How is working memory capacity limited, and why? Curr Dir Psychol Sci 19(1):51\u201357","journal-title":"Curr Dir Psychol Sci"},{"key":"12728_CR8","doi-asserted-by":"crossref","unstructured":"Feleus S., et al., (2024) Medication Use and Treatment Indications in Huntington\u2019s Disease; Analyses from a Large Cohort. Mov Disord Clin Pract, under review.","DOI":"10.1002\/mdc3.14230"},{"issue":"8","key":"12728_CR9","first-page":"295","volume":"5","author":"H Baltacioglu","year":"2018","unstructured":"Baltacioglu H, Eroglu O, Coskun F (2018) An investigation of inappropriate medication use and dangerous drug combinations in elderly patients with polypharmacy. Med Sci Discovery 5(8):295\u2013302","journal-title":"Med Sci Discovery"},{"key":"12728_CR10","doi-asserted-by":"publisher","first-page":"263300402312046","DOI":"10.1177\/26330040231204643","volume":"4","author":"S Feleus","year":"2023","unstructured":"Feleus S et al (2023) Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington\u2019s disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics. Ther Adv Rare Dis 4:26330040231204644","journal-title":"Ther Adv Rare Dis"},{"issue":"2","key":"12728_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136\u2013142","journal-title":"Mov Disord"},{"issue":"1","key":"12728_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1176\/appi.neuropsych.13070169","volume":"27","author":"J Callaghan","year":"2015","unstructured":"Callaghan J et al (2015) Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington\u2019s disease (PBA-s) in the TRACK-HD and REGISTRY studies. J Neuropsychiatr Clin Neurosci 27(1):59\u201364","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"12728_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.667420","volume":"12","author":"S Sathe","year":"2021","unstructured":"Sathe S et al (2021) Enroll-HD: an Integrated Clinical Research Platform and Worldwide Observational Study for Huntington\u2019s Disease. Front Neurol 12:667420","journal-title":"Front Neurol"},{"issue":"4","key":"12728_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010505","volume":"6","author":"M O'Dwyer","year":"2016","unstructured":"O\u2019Dwyer M et al (2016) Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open 6(4):e010505","journal-title":"BMJ Open"},{"issue":"4","key":"12728_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA et al (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10(4):204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"12728_CR16","unstructured":"Smith A. (2007) Symbol digits modalities test: Manual (10th printing). Western Psychological Services: Los Angeles"},{"issue":"1","key":"12728_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1037\/0894-4105.8.1.25","volume":"8","author":"AU Monsch","year":"1994","unstructured":"Monsch AU et al (1994) A comparison of category and letter fluency in Alzheimer\u2019s disease and Huntington\u2019s disease. Neuropsychology 8(1):25","journal-title":"Neuropsychology"},{"issue":"6","key":"12728_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1037\/h0054651","volume":"18","author":"JR Stroop","year":"1935","unstructured":"Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18(6):643","journal-title":"J Exp Psychol"},{"issue":"3","key":"12728_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8(3):271\u2013276","journal-title":"Percept Mot Skills"},{"issue":"10","key":"12728_CR20","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1007\/s00415-023-11823-x","volume":"270","author":"A M\u00fchlb\u00e4ck","year":"2023","unstructured":"M\u00fchlb\u00e4ck A et al (2023) Establishing normative data for the evaluation of cognitive performance in Huntington\u2019s disease considering the impact of gender, age, language, and education. J Neurol 270(10):4903\u20134913","journal-title":"J Neurol"},{"key":"12728_CR21","unstructured":"Luijkx R. and M. de Heus (2008) The educational system of the Netherlands. The international standard classification of education (ISCED-97). An evaluation of content and criterion validity for. 15:47\u201375."},{"key":"12728_CR22","unstructured":"R Core Team. (2023) R: A Language and Environment for Statistical Computing https:\/\/www.R-project.org\/."},{"key":"12728_CR23","doi-asserted-by":"crossref","unstructured":"L\u00fcdecke D. et al., (2022) easystats: Framework for Easy Statistical Modeling, Visualization, and Reporting. CRAN,.","DOI":"10.32614\/CRAN.package.easystats"},{"issue":"43","key":"12728_CR24","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H et al (2019) Welcome to the tidyverse. J Open Source Software 4(43):1686","journal-title":"J Open Source Software"},{"issue":"12","key":"12728_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1177\/1060028018784905","volume":"52","author":"MM Ebbens","year":"2018","unstructured":"Ebbens MM et al (2018) Prospective validation of a risk prediction model to identify high-risk patients for medication errors at hospital admission. Ann Pharmacother 52(12):1211\u20131217","journal-title":"Ann Pharmacother"},{"issue":"7","key":"12728_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/mdc3.13789","volume":"10","author":"A Viudez-Mart\u00ednez","year":"2023","unstructured":"Viudez-Mart\u00ednez A et al (2023) Antiparkinsonian medication reconciliation as a strategy to improve safety by preventing medication errors. Movement Disorders Clinical Practice 10(7):1090\u20131098","journal-title":"Movement Disorders Clinical Practice"},{"key":"12728_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105097","volume":"80","author":"M Staniki\u0107","year":"2023","unstructured":"Staniki\u0107 M et al (2023) Self-reports by persons with multiple sclerosis are an adequate surrogate for healthcare provider data on disease-modifying therapy and multiple sclerosis type. Multiple Sclerosis Related Disorders 80:105097","journal-title":"Multiple Sclerosis Related Disorders"},{"issue":"10","key":"12728_CR28","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.neuropsychologia.2006.01.015","volume":"44","author":"A Montoya","year":"2006","unstructured":"Montoya A et al (2006) Episodic memory impairment in Huntington\u2019s disease: a meta-analysis. Neuropsychologia 44(10):1984\u20131994","journal-title":"Neuropsychologia"},{"key":"12728_CR29","unstructured":"Ministry of Education Culture and Science. Educational level of the general population [Onderwijsniveau van de bevolking] https:\/\/www.ocwincijfers.nl\/sectoren\/ocw-internationaal\/onderwijs\/opleidingsniveau-van-de-bevolking. 2022 13 Jun 2023 23 Mar 2024"},{"issue":"6","key":"12728_CR30","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/13803390903313564","volume":"32","author":"LJ Beglinger","year":"2010","unstructured":"Beglinger LJ et al (2010) Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol 32(6):573\u2013578","journal-title":"J Clin Exp Neuropsychol"},{"key":"12728_CR31","unstructured":"Hoffman-La Roche. A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease; https:\/\/clinicaltrials.gov\/study\/NCT03761849?cond=huntington&term=generation&rank=6. 2018 01 MAR 2024 28 MAR 2024"},{"key":"12728_CR32","unstructured":"Prilenia. PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD.; https:\/\/clinicaltrials.gov\/study\/NCT04556656?cond=huntington&rank=1. 2020 18 NOV 2023 28 MAR 2024]"},{"key":"12728_CR33","unstructured":"Enroll-HD Acknowledgement. https:\/\/enroll-hd.org\/enrollhd_documents\/ENROLL-HD_AcknowledgementsListPDS6_v1.0_20230119.pdf. 2023 28 Nov 2023"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12728-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12728-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T17:50:19Z","timestamp":1738173019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12728-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["12728"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12728-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was supported by private HD community donations. We received no funding from commercial or not-for-profit parties. HD-MED is an investigator-initiated study set up by the Department of Neurology and Department of Clinical Pharmacy and Toxicology of the Leiden University Medical Center. The authors declare that there are no conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants in the HD-MED and ENROLL-HD study gave written informed consent to participate in the study and have their data published in international journals. The HD-MED study is approved by the medical research ethics committee Leiden Den Haag Delft under number NL70391.058.19 and is registered in the International Clinical Trials Registry Platform under number NL-OMON55123. The HD-med study is in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All sites participating in the ENROLL-HD study have obtained local ethical approval. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, and consent to participate and publish"}}],"article-number":"55"}}